VistaGen Therapeutics, Inc.
VTGN
$3.22
$0.1555.07%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1,726.67% | -106.41% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1,726.67% | -106.41% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 1,726.67% | -106.41% | |||
| SG&A Expenses | 2.27% | 5.53% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.83% | -5.69% | |||
| Operating Income | -9.03% | 4.13% | |||
| Income Before Tax | -10.71% | 3.22% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.71% | 3.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.71% | 3.22% | |||
| EBIT | -9.03% | 4.13% | |||
| EBITDA | -9.06% | 4.15% | |||
| EPS Basic | -9.42% | 5.82% | |||
| Normalized Basic EPS | -9.44% | 5.82% | |||
| EPS Diluted | -9.42% | 5.82% | |||
| Normalized Diluted EPS | -9.44% | 5.82% | |||
| Average Basic Shares Outstanding | 1.17% | 2.76% | |||
| Average Diluted Shares Outstanding | 1.17% | 2.76% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||